P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic

Autor: Bronowicki, J.-P., Fontaine, H., Dufour, C., Zoulim, F., Larrey, D., Canva, V., Samuel, D., Poynard, T., Marcellin, P., De Ledinghen, V., Bourlière, M., Alric, L., Zarski, J.-P., Raabe, J.-J., Serfaty, L., Metivier, S., Riachi, G., Abergel, A., Loustaud-Ratti, V., Causse, X., Guyader, D., Bernard, P.-H., Attali, P., Di Martino, V., Cacoub, P., Cales, P., Tran, A., Rosa, I., Grando-Lemaire, V., Portal, I., Dao, T., Lucidarme, D., Fontanges, T., Barthe, Y., Pawlotsky, J.-M., Pol, S., Carrat, F., Hezode, C.
Zdroj: In Journal of Hepatology April 2015 62 Supplement 2:S617-S618
Databáze: ScienceDirect